A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I

ConclusionsResults of this pilot study do not support the use of minocycline to prevent CIPN, but suggest that it may reduce P-APS and decrease fatigue; further study of the impact of this agent on those endpoints may be warranted.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research